Article

Neural Stem Cells Improve Memory in an Inducible Mouse Model of Neuronal Loss

Department of Neurobiology and Behavior, University of California, Irvine, Irvine, California 92697, USA.
The Journal of Neuroscience : The Official Journal of the Society for Neuroscience (Impact Factor: 6.34). 11/2007; 27(44):11925-33. DOI: 10.1523/JNEUROSCI.1627-07.2007
Source: PubMed

ABSTRACT

Neuronal loss is a major pathological outcome of many common neurological disorders, including ischemia, traumatic brain injury, and Alzheimer disease. Stem cell-based approaches have received considerable attention as a potential means of treatment, although it remains to be determined whether stem cells can ameliorate memory dysfunction, a devastating component of these disorders. We generated a transgenic mouse model in which the tetracycline-off system is used to regulate expression of diphtheria toxin A chain. After induction, we find progressive neuronal loss primarily within the hippocampus, leading to specific impairments in memory. We find that neural stem cells transplanted into the brain after neuronal ablation survive, migrate, differentiate and, most significantly, improve memory. These results show that stem cells may have therapeutic value in diseases and conditions that result in memory loss.

Download full-text

Full-text

Available from: Mathew Blurton-Jones, Nov 26, 2015
  • Source
    • "No examples of fully matured GFP/NeuN double-labeled neurons were detected (Figure S1). Taken together, these findings are consistent with previous reports that murine NSCs predominantly acquire gliogenic phenotypes when transplanted into non-neurogenic regions and with other studies that utilized these postnatal day 1-derived cells (Herrera et al., 1999; Yamasaki et al., 2007; Blurton-Jones et al., 2009). Interestingly, no significant differences in NSC differentiation were detected between ASO and WT transplanted mice (Figure 1I), and each cell type migrated with similar distribution and distance from the injection site (Figure S1A). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Accumulation of α-synuclein (α-syn) into insoluble aggregates occurs in several related disorders collectively referred to as synucleinopathies. To date, studies have used neural stem cells (NSCs) to examine questions about α-syn propagation, but have overlooked the therapeutic potential of NSC transplantation to modulate cognition in disorders such as dementia with Lewy bodies or Parkinson's disease dementia. Here, we show that striatal transplantation of NSCs into aged α-syn transgenic mice significantly improves performance in multiple cognitive and motor domains. This recovery is associated with NSC expression of brain-derived neurotrophic factor (BDNF), which restores depleted levels and modulates dopaminergic and glutamatergic systems. Most importantly, transplantation of BDNF-depleted NSCs fails to improve behavior, whereas AAV-mediated BDNF delivery mimics the benefits of NSC transplantation, supporting a critical role for this neurotrophin in functional improvement. Thus, NSC transplantation could offer a promising approach to treat the understudied yet devastating cognitive components of many synucleinopathies.
    Full-text · Article · Oct 2015 · Stem Cell Reports
  • Source
    • "Also transplantation of glial-restricted progenitor cells & olfactory ensheathing stem cells (OESCs) shows positive effects in the survival of the ALS disease[65,66]. Loss of neurotrophic factors & growth factors (including GDNF, BDNF, VEGF, and IGF-1) has been implicated in the pathogenesis of ALS[67]. These factors play a neuroprotective role for motor neurons also physical exercise appeared to be beneficial in animal experiments68697071. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Neuroregeneration (NR) is a long-sought medical dream which has intrigued vast research in the past decades. A traditional physiologic dogma that central nervous system does not regenerate has been strongly challenged in the recent years since the advent of the stem cell era. Stem cell research in the regenerative field passes through three main stages. The first stage is the in-vitro experiments which studies the exact molecular and cellular mechanisms underlying stem cell-mediated NR. The second stage is the application of these data in experimental animal settings to provide "proof of concept" of stem cell therapy in animal models. The final step is the translation of these data in pilot clinical trials. In this review, we will try to gather the different data of stem cell-mediated NR from various experimental and clinical researches.
    Full-text · Article · Jun 2015
  • Source
    • "To study the adaptive response of the hippocampus following neuronal loss, we used the innovative CaM/Tet-DTA mouse model that induces hippocampal neuronal loss [32], [33]. This double transgene system consists of a transactivator driven by a constitutively active CaM-KII-alpha promoter, which in turns drive expression of a diphtheria toxin. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Neuronal loss is a common component of a variety of neurodegenerative disorders (including Alzheimer's, Parkinson's, and Huntington's disease) and brain traumas (stroke, epilepsy, and traumatic brain injury). One brain region that commonly exhibits neuronal loss in several neurodegenerative disorders is the hippocampus, an area of the brain critical for the formation and retrieval of memories. Long-lasting and sometimes unrecoverable deficits caused by neuronal loss present a unique challenge for clinicians and for researchers who attempt to model these traumas in animals. Can these deficits be recovered, and if so, is the brain capable of regeneration following neuronal loss? To address this significant question, we utilized the innovative CaM/Tet-DTA mouse model that selectively induces neuronal ablation. We found that we are able to inflict a consistent and significant lesion to the hippocampus, resulting in hippocampally-dependent behavioral deficits and a long-lasting upregulation in neurogenesis, suggesting that this process might be a critical part of hippocampal recovery. In addition, we provide novel evidence of angiogenic and vasculature changes following hippocampal neuronal loss in CaM/Tet-DTA mice. We posit that angiogenesis may be an important factor that promotes neurogenic upregulation following hippocampal neuronal loss, and both factors, angiogenesis and neurogenesis, can contribute to the adaptive response of the brain for behavioral recovery.
    Full-text · Article · Sep 2014 · PLoS ONE
Show more